Related Experiment Video
Updated: May 2, 2026

12:17
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
11.3K
Aortic Annular Enlargement vs Isolated Aortic Valve Replacement in Patients With Matched Annulus
Alexander Makkinejad1, Katelyn Monaghan2, Sarah A Chen3
1Department of Surgery, UF Health, University of Florida, Gainesville, Florida.
The Annals of Thoracic Surgery
|August 5, 2024
Summary
Aortic annular enlargement may benefit patients with small aortic annuli undergoing aortic valve replacement (AVR). This procedure improved midterm survival and reduced patient-prosthesis mismatch, proving protective against mortality.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Surgery
- Aortic Valve Replacement
Background:
- Small native aortic annuli (≤23 mm) pose challenges in aortic valve replacement (AVR).
- The impact of aortic annular enlargement (AAE) on midterm outcomes in these patients is not fully understood.
Purpose of the Study:
- To evaluate the effect of AAE on midterm outcomes in patients undergoing isolated AVR with small native aortic annuli.
- To compare outcomes between AVR with and without AAE using propensity score matching.
Main Methods:
- Retrospective analysis of 1328 patients undergoing isolated AVR from 2011-2022.
- 1163 patients without AAE (AVR group) and 165 with AAE (AVR+AAE group).
- Propensity score matching created 112 pairs to control for baseline characteristics and annulus size.
Main Results:
- Median annulus size was 23 mm in both groups; prosthesis size was larger in the AVR+AAE group (25 mm vs 23 mm).
- The AVR+AAE group showed significantly improved 6-year survival (98% vs 74%) and was independently associated with reduced mortality (HR 0.19).
- Operative mortality and moderate/severe patient-prosthesis mismatch rates were similar between groups.
Conclusions:
- Aortic annular enlargement may be beneficial for patients with small native aortic annuli undergoing isolated AVR.
- AAE is an independent protective factor for midterm mortality in this patient cohort.
- Further research may explore optimal patient selection for AAE.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753

